---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-317577"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:22:28.867226+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Immunovant raises $550M via 26.2M share offering at $21.00/share

## Summary
- Gross proceeds ~$550M from 26.2M shares priced at $21.00/share.
- Controlling stockholder Roivant Sciences Ltd. participated in the offering.
- Offering closed December 12, 2025; Leerink Partners acted as underwriter.

## SEC filing metadata
- accession: 0001193125-25-317577
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000119312525317577/0001193125-25-317577-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000119312525317577/d68980d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-317577
- JSON: https://secwatch.observer/filing/0001193125-25-317577.json
- Plain text: https://secwatch.observer/filing/0001193125-25-317577.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.